Tetsuya Nagata

5.2k total citations · 1 hit paper
107 papers, 3.8k citations indexed

About

Tetsuya Nagata is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Tetsuya Nagata has authored 107 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 15 papers in Neurology. Recurrent topics in Tetsuya Nagata's work include RNA Interference and Gene Delivery (30 papers), Muscle Physiology and Disorders (22 papers) and DNA and Nucleic Acid Chemistry (17 papers). Tetsuya Nagata is often cited by papers focused on RNA Interference and Gene Delivery (30 papers), Muscle Physiology and Disorders (22 papers) and DNA and Nucleic Acid Chemistry (17 papers). Tetsuya Nagata collaborates with scholars based in Japan, United States and Canada. Tetsuya Nagata's co-authors include Serge Przedborski, Hynek Wichterle, Diane B. Ré, Makiko Nagai, Thomas M. Jessell, Alcmène Chalazonitis, Yoshitsugu Aoki, Shin’ichi Takeda, Takashi Saito and Akinori Nakamura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Tetsuya Nagata

103 papers receiving 3.8k citations

Hit Papers

Astrocytes expressing ALS-linked mutated SOD1 release fac... 2007 2026 2013 2019 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuya Nagata Japan 28 2.3k 1.1k 836 716 517 107 3.8k
Roberto Del Bo Italy 36 2.0k 0.9× 913 0.8× 982 1.2× 736 1.0× 593 1.1× 88 3.5k
Andoni Echaniz‐Laguna France 34 1.7k 0.7× 1.4k 1.3× 935 1.1× 937 1.3× 247 0.5× 138 3.6k
Cyril Goizet France 35 1.7k 0.7× 762 0.7× 735 0.9× 1.1k 1.6× 517 1.0× 133 4.0k
Carlos J. Miranda United States 19 1.4k 0.6× 1.2k 1.0× 693 0.8× 754 1.1× 675 1.3× 35 2.8k
Cinzia Gellera Italy 41 3.7k 1.6× 1.7k 1.6× 813 1.0× 2.3k 3.2× 531 1.0× 155 5.5k
Hitoshi Warita Japan 32 1.0k 0.5× 1.1k 1.0× 646 0.8× 523 0.7× 394 0.8× 113 2.4k
Zheng Gang Zhang United States 40 2.7k 1.2× 704 0.6× 886 1.1× 958 1.3× 1.4k 2.8× 85 6.0k
Mario Sabatelli Italy 36 1.3k 0.6× 2.6k 2.3× 997 1.2× 1.4k 1.9× 572 1.1× 179 4.0k
Pietro Fratta United Kingdom 32 2.0k 0.9× 2.6k 2.4× 1.6k 2.0× 920 1.3× 483 0.9× 59 4.0k
Marina Kennerson Australia 27 1.5k 0.6× 762 0.7× 460 0.6× 1.4k 1.9× 658 1.3× 95 3.0k

Countries citing papers authored by Tetsuya Nagata

Since Specialization
Citations

This map shows the geographic impact of Tetsuya Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Nagata more than expected).

Fields of papers citing papers by Tetsuya Nagata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Nagata. The network helps show where Tetsuya Nagata may publish in the future.

Co-authorship network of co-authors of Tetsuya Nagata

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Nagata. A scholar is included among the top collaborators of Tetsuya Nagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Nagata. Tetsuya Nagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagata, Tetsuya, Hiroya Kuwahara, Kie Yoshida‐Tanaka, et al.. (2024). DNA/RNA heteroduplex technology with cationic oligopeptide reduces class-related adverse effects of nucleic acid drugs. Molecular Therapy — Nucleic Acids. 35(3). 102289–102289. 1 indexed citations
2.
Nagata, Tetsuya, Kensuke Ihara, Jun Tanihata, et al.. (2024). Heteroduplex oligonucleotide technology boosts oligonucleotide splice switching activity of morpholino oligomers in a Duchenne muscular dystrophy mouse model. Nature Communications. 15(1). 7530–7530. 5 indexed citations
3.
Hori, Mao, Nan Qiao, Beob Soo Kim, et al.. (2024). Hydrophobicity Tuning of Cationic Polyaspartamide Derivatives for Enhanced Antisense Oligonucleotide Delivery. Bioconjugate Chemistry. 35(2). 125–131. 4 indexed citations
4.
Li, Fuying, Satoru Ishibashi, S. Yamamoto, et al.. (2023). Preferential delivery of lipid-ligand conjugated DNA/RNA heteroduplex oligonucleotide to ischemic brain in hyperacute stage. Molecular Therapy. 31(4). 1106–1122.
5.
Nagata, Tetsuya, et al.. (2022). Regulation of activated microglia and macrophages by systemically administered DNA/RNA heteroduplex oligonucleotides. Molecular Therapy. 30(6). 2210–2223. 9 indexed citations
6.
Kaburagi, Hidetoshi, Tetsuya Nagata, Mitsuhiro Enomoto, et al.. (2022). Systemic DNA/RNA heteroduplex oligonucleotide administration for regulating the gene expression of dorsal root ganglion and sciatic nerve. Molecular Therapy — Nucleic Acids. 28. 910–919. 7 indexed citations
8.
Nagata, Tetsuya, Kensuke Ihara, Kie Yoshida‐Tanaka, et al.. (2021). DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo. Nature Communications. 12(1). 7344–7344. 9 indexed citations
10.
Yoshioka, Kotaro, Haruka Miyata, Kie Yoshida‐Tanaka, et al.. (2019). Highly efficient silencing of microRNA by heteroduplex oligonucleotides. Nucleic Acids Research. 47(14). 7321–7332. 34 indexed citations
11.
Yoshioka, Kotaro, et al.. (2018). Efficacy of microRNA silencing by lipid-conjugated double-stranded antisense oligonucleotides. 65(2). 83–88. 1 indexed citations
12.
Lim, Kenji Rowel Q., Yusuke Echigoya, Tetsuya Nagata, et al.. (2018). Efficacy of Multi-exon Skipping Treatment in Duchenne Muscular Dystrophy Dog Model Neonates. Molecular Therapy. 27(1). 76–86. 23 indexed citations
13.
Suzuki, Hitoshi, Yoshitsugu Aoki, T. Kameyama, et al.. (2016). Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot. International Journal of Molecular Sciences. 17(10). 1722–1722. 36 indexed citations
14.
Yokota, Toshifumi, Akinori Nakamura, Tetsuya Nagata, et al.. (2012). Extensive and Prolonged Restoration of Dystrophin Expression with Vivo-Morpholino-Mediated Multiple Exon Skipping in Dystrophic Dogs. Nucleic Acid Therapeutics. 22(5). 306–315. 56 indexed citations
15.
Ohta, Yasuyuki, Tatsushi Kamiya, Makiko Nagai, et al.. (2008). Therapeutic benefits of intrathecal protein therapy in a mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience Research. 86(13). 3028–3037. 26 indexed citations
16.
Sadakane, Yutaka, Keiko Konoha, & Tetsuya Nagata. (2008). Improvement of screening for protective substances against zinc-induced neuronal cell death. 25. 41–45. 2 indexed citations
17.
Konoha, Keiko, Tetsuya Nagata, Yutaka Sadakane, & Masahiro Kawahara. (2007). Neurotoxicity of aluminum hydroxyl polymer on primary cultured neurons of rat cerebral cortex. 18(4). 395–399. 2 indexed citations
18.
Sadakane, Yutaka, Keiko Konoha, & Tetsuya Nagata. (2007). Protective Activity of the Extracts from Japanese eel (Anguilla japonica) Against Zinc-induced Neuronal Cell Death: Carnosine and an Unknown Substance. 24. 98–105. 10 indexed citations
19.
Hirano, Makito, Aya Yamamoto, Toshio Mori, et al.. (2007). DNA single‐strand break repair is impaired in aprataxin‐related ataxia. Annals of Neurology. 61(2). 162–174. 62 indexed citations
20.
Nagata, Tetsuya, Hongjun Ma, & Nobuteru Usuda. (1986). 140 Radioautographic study of nucleic acid synthesis in aging mice pancreatic acinar cells.. ACTA HISTOCHEMICA ET CYTOCHEMICA. 19(27). 396. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026